APP and Alzheimer disease: Both ADAM17 and ADAM10 act as relevant alpha-secretases to cleave the amyloid precursor protein APP and produce a soluble and non-amyloidogenic fragment, APPsα, thus having a neuroprotective effect precluding the formation of pathogenic Aβ peptides and for AD.